Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRC 17536 in Painful Diabetic Peripheral Neuropathy
NCT01726413Phase 2Completed
- Sponsor
- Glenmark Pharmaceuticals
- Start
- Nov 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of GRC-17536 in diabetic peripheral neuropathy (DPN), sponsored by Glenmark Pharmaceuticals. Started Nov 2012; status: completed.
02
Drugs
GRC-17536
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01726413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01726413.